
Nanocopoeia
New Brighton, MN, United States nanocopoeia.com From their website, Nov 2026
Work here? Claim this listing
About
Nanocopoeia is a privately held specialty research company in the Twin Cities area of Minnesota. It focuses on improving drug product performance for insoluble, low-bioavailability compounds and on generating macro-particles for oral-solid drug development.
Services
Drug formulation development
Develops drug formulations using common pharmaceutical grade excipients and solvents.
ElectronanoSpray (ENS) atomization technology
Uses a proprietary high-voltage unipolar atomization process based on Taylor Cone cone-jet mode to create homogeneous macro-scale drug formulation particles.
Out-licensing
Offers technology through out-licensing business models.
Insolubility problem solving
Works on high-value, high-barrier insolubility issues in drug products.
Bioavailability enhancement
Aims to improve bio-availability performance for low-solubility drugs.
ElectronanoSpray technology application
Uses proprietary atomization technology to generate homogeneous, macro-scale drug formulation particles.
Co-development partnering
Collaborates with partners on shared development programs.
Instruments and platforms
- ElectronanoSpray (ENS)
Modalities and species
- Modalities
- Oral-solid drug development
Industries served
- Biotechnology
- Pharmaceutical
Details
- Founded
- 2001
- Quality
- ICH requirements (residual solvents are stated to be well below ICH requirements)
- Address
- 639 Campus Drive New Brighton, MN 55112
- Sites
- St. Paul, United States
- New Brighton, MN, USA
- St. Paul, MN, USA
- Phone
- 651.209.1184